HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Z160

an N- and T-type calcium channel blocker

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperazines: 26
    - Z160: 1

Experts

1.	Bonuccelli, Catherine M: 1 article (11/2004)
2.	Chen, Yusong: 1 article (11/2004)
3.	Korenblat, Phillip E: 1 article (11/2004)
4.	Miller, Christopher J: 1 article (11/2004)
5.	Nowak, Richard M: 1 article (11/2004)
6.	Silverman, Robert A: 1 article (11/2004)
7.	Simonson, Steven G: 1 article (11/2004)
8.	Skobeloff, Emil: 1 article (11/2004)

Related Diseases

1.	Dyspnea (Shortness of Breath) 11/01/2004 - "These findings were supported by a significant improvement in FEV(1) and dyspnea in the ED with the use of Z160 therapy, and by greater improvement in FEV(1) and symptoms during the outpatient period for patients treated with Z20. "
2.	Asthma (Bronchial Asthma) 11/01/2004 - "A total of 641 patients presenting to the ED with acute asthma were randomized to receive either single-dose zafirlukast, 160 mg (Z160) [162 patients], zafirlukast, 20 mg (Z20) [158 patients]), or placebo (321 patients) as adjunct treatment to standard care in this double-blind, multicenter trial. "

Related Drugs and Biologics

1.	zafirlukast (Accolate)

Related Therapies and Procedures

1.	Therapeutics